PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Bilton, Diana
TI  - LAI Improves Pulmonary Function in CF
DP  - 2014 Sep 01
TA  - MD Conference Express
PG  - 22--23
VI  - 14
IP  - 11
4099  - http://mdc.sagepub.com/content/14/11/22.2.short
4100  - http://mdc.sagepub.com/content/14/11/22.2.full
AB  - Treatment of chronic bronchopulmonary infection by Pseudomonas aeruginosa in patients with cystic fibrosis (CF) with liposomal amikacin for inhalation (LAI) resulted in improved pulmonary function and decreased P aeruginosa sputum concentration in an interim analysis. This article discusses interim data from the Long Term Safety and Tolerability of Open-Label Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients With Chronic Infection due to Pseudomonas aeruginosa trial [CLEAR-110; NCT01316276; Bilton D et al. Am J Respir Crit Care Med 2014].